Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 3.26M $771.10M March 31, 2014
Citi 3.04M $719.61M March 31, 2014
MORGAN STANLEY 1.95M $460.80M March 31, 2014
SUSQUEHANNA INTERNATIONAL 1.91M $451.37M March 31, 2014
Barclays 1.67M $394.53M March 31, 2014
Bank of America Corporation 1.48M $350.18M March 31, 2014
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
HAP Trading 1.33M $3.52M March 31, 2014
UBS AG 1.29M $305.98M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.22M $288.50M March 31, 2014
JANE STREET 1.02M $241.19M March 31, 2014
Archer Capital Management 980000 $81.15M March 31, 2012
Mirae Asset Global Investments 699344 $165.05M March 31, 2014
Churchill Management 594625 $152.84M June 30, 2014
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Credit Suisse AG 406379 $96.07M March 31, 2014
OrbiMed Advisors 350000 $43.16M March 31, 2012
LPL Financial 319571 $45.57M Sept. 30, 2012
Arrowgrass Capital Partners 286600 $65.08M Dec. 31, 2013
Rathbones Brothers 276802 $8.89M March 31, 2014
Perceptive Advisors 269400 $46.84M June 30, 2013
Wells Fargo & Company 263339 $62.21M March 31, 2014
DAVENPORT & CO 247785 $43.08M Sept. 30, 2013
Bank of Nova Scotia 222753 $52.66M March 31, 2014
Quantitative Investment Management 218800 $51.72M March 31, 2014
Jefferies 211362 $27.47M June 30, 2012
Two Sigma Investments 203224 $48.05M March 31, 2014
JPMORGAN CHASE & CO 202578 $47.88M March 31, 2014
Kingdon Capital Management 200000 $3.08M Sept. 30, 2013
FMR 195424 $44.37M Dec. 31, 2013

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Neuberger Berman Sept. 30, 2011 197932 $18.48M
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M